NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Australian Pharmaceutical Industries Limited (AU: API)
API Technical Analysis
5
As on 1st Apr 2022 API STOCK Price closed @ 1.53 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.24 & Strong Buy for SHORT-TERM with Stoploss of 1.18 we also expect STOCK to react on Following IMPORTANT LEVELS. |
APISTOCK Price
Open | 1.53 | Change | Price | % |
High | 1.53 | 1 Day | 0.00 | 0.00 |
Low | 1.53 | 1 Week | 0.00 | 0.00 |
Close | 1.53 | 1 Month | 0.01 | 0.66 |
Volume | N/A | 1 Year | 0.47 | 44.34 |
52 Week High 1.75 | 52 Week Low 1.06 |
AU Australia Most Active Stocks
SYA | 0.03 | % |
M2R | 0.01 | % |
ACW | 0.04 | % |
QPM | 0.04 | % |
BCB | 0.01 | % |
YAL | 5.35 | % |
RED | 0.36 | % |
LRS | 0.22 | % |
NAG | 0.02 | % |
STX | 0.20 | % |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
API Daily Charts |
API Intraday Charts |
Whats New @ Bazaartrend |
API Free Analysis |
|
API Important Levels Intraday
RESISTANCE | 1.53 |
RESISTANCE | 1.53 |
RESISTANCE | 1.53 |
RESISTANCE | 1.53 |
RESISTANCE | 1.53 |
RESISTANCE | 1.53 |
RESISTANCE | 1.53 |
RESISTANCE | 1.53 |
API Forecast September 2024
4th UP Forecast | 2.05 |
3rd UP Forecast | 1.88 |
2nd UP Forecast | 1.78 |
1st UP Forecast | 1.68 |
1st DOWN Forecast | 1.38 |
2nd DOWN Forecast | 1.28 |
3rd DOWN Forecast | 1.18 |
4th DOWN Forecast | 1.01 |
API Weekly Forecast
4th UP Forecast | 1.66 |
3rd UP Forecast | 1.62 |
2nd UP Forecast | 1.59 |
1st UP Forecast | 1.57 |
1st DOWN Forecast | 1.49 |
2nd DOWN Forecast | 1.47 |
3rd DOWN Forecast | 1.44 |
4th DOWN Forecast | 1.40 |
API Forecast2024
4th UP Forecast | 2.9 |
3rd UP Forecast | 2.46 |
2nd UP Forecast | 2.19 |
1st UP Forecast | 1.92 |
1st DOWN Forecast | 1.14 |
2nd DOWN Forecast | 0.87 |
3rd DOWN Forecast | 0.6 |
4th DOWN Forecast | 0.16 |
Australian Pharmaceutical Industries Limited ( AU Australia Symbol : API )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
API Other Details
Segment | EQ | |
Market Capital | 751300416.00 | |
Sector | Healthcare | |
Industry | Medical Distribution | |
Offical website | > echo $website ; ?> |
API Address
![]() |
API Latest News
API Business Profile
Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia. Address: 250 Camberwell Road, Camberwell, VIC, Australia, 3124
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service